 |
|
Ibuprofen Destroys Aspirin's Positive Effect on Stroke Risk
March 13, 2008BUFFALO, N.Y. -- Stroke patients who use ibuprofen for arthritis pain or other conditions while taking aspirin to reduce the risk of a second stroke undermine aspirin's ability to act as an anti-platelet agent, researchers at the University at Buffalo have shown.
In a cohort of patients seen by physicians at two offices of the Dent Neurologic Institute, 28 patients were identified as taking both aspirin and ibuprofen (a nonsteroidal anti-inflammatory drug, or NSAID) daily and all were found to have no anti-platelet effect from their daily aspirin.
Thirteen of these patients were being seen because they had a second stroke/TIA while taking aspirin and a NSAID, and were platelet non-responsive to aspirin (aspirin resistant) at the time of that stroke.
The researchers found that when 18 of the 28 patients returned for a second neurological visit after discontinuing NSAID use and were tested again, all had regained their aspirin sensitivity and its ability to prevent blood platelets from aggregating and blocking arteries.
The study is the first to show the clinical consequences of the aspirin/NSAID interaction in patients being treated for prevention of a second stroke, and presents a possible explanation of the mechanism of action.
The Food and Drug Administration currently warns that ibuprofen might make aspirin less effective, but states that the clinical implications of the interaction have not been evaluated.
"This interaction between aspirin and ibuprofen or prescription NSAID's is one of the best-known, but well-kept secrets in stroke medicine," said Francis M. Gengo, Pharm.D., lead researcher on the study.
"It's unfortunate that clinicians and patients often are unaware of this interaction. Whatever number of patients who have had strokes because of the interaction between aspirin and NSAIDs, those strokes were preventable."
Gengo is professor of neurology in the UB School of Medicine and Biomedical Sciences and professor of pharmacy practice in the UB School of Pharmacy and Pharmaceutical Sciences. Results of the study were published in the January issue of the Journal of Clinical Pharmacology.
"We first looked at this issue way back in 1992 in a study conducted in normal volunteers, but it was published as an abstract only," he said. "We never followed through with a manuscript, but another group published an elegant study in the New England Journal of Medicine showing this interaction at least seven years ago.
"When we began to assess this in our stroke patients, a surprisingly high percentage of a group of 653 patients, around 17 percent, were taking aspirin plus Motrin [a brand of ibuprofen].
"The prescription medication Aggrenox, which also is used for secondary stroke prevention and contains aspirin and extended release dipyridamole, is affected the same way as aspirin," Gengo continued. "In preventing strokes, it is statistically a little better than aspirin but more expensive.
"However, one of the most common side effects when you first start taking Aggrenox is headache, so some physicians, pharmacists or physician assistants tell patients to take a Motrin so they don't get a headache. This likely would negate the effects of the aspirin and extended release dipyridamole. Those patients might as well take this expensive drug and flush it down the toilet."
Gengo and colleagues verified with urine testing that all 18 patients, six men and 12 women, were taking their aspirin or aspirin and extended release dipyridamole as directed. Information on the concomitant use of NSAIDS was obtained from patient interviews. Data from the earlier healthy volunteer study showed the magnitude and time course of each drug administered separately, as well as in combination.
The UB study provides important information, Gengo noted, because in most previous studies, measurements were taken only at one point in time, and that time point may have been during the 4-6 hour window when concentrations of NSAIDS were sufficiently high to inhibit aggregation.
"Our data report the entire time course of this interaction," he said. "The results showed that platelets resumed aggregating within 4-6 hours when aspirin and ibuprofen were taken close together, leaving patients with no anti-platelet effect for 18-20 hours a day. Normally, a single dose of aspirin has an effect on platelet aggregation for 72-96 hours," Gengo said.
"When I lecture to pharmacy students, I tell them 'Please, you have a responsibility to the patients you care for. When you counsel a patient taking aspirin/extended release dipyrdamole to lower stroke risk, tell patients they may have some transient headaches, but to avoid ibuprofen. You may have prevented that patient from having another stroke.'"
This study was supported by the Dent Family Foundation.
UB/Dent personnel who also contributed to the study were Michelle Rainka, Pharm.D., UB adjunct instructor of pharmacy practice; Donald E. Mager, Pharm.D., UB assistant professor of pharmaceutical sciences, and Vernice Bates, M.D., UB clinical associate professor of neurology. Matthew Robson and Michael Gengo, research assistants at the Dent Neurologic Institute, and Lisa Rubin, Pharm.D., a former UB student, also contributed to the research.
The University at Buffalo is a premier research-intensive public university, a flagship institution in the State University of New York system and its largest and most comprehensive campus. UB's more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. The School of Medicine and Biomedical Sciences, School of Dental Medicine, School of Nursing, School of Pharmacy and Pharmaceutical Sciences and School of Public Health and Health Professions are the five schools that constitute UB's Academic Health Center. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.
The University at Buffalo
The researchers found that when 18 of the 28 patients returned for a second neurological visit after discontinuing NSAID use and were tested again, all had regained their aspirin sensitivity and its ability to prevent blood platelets from aggregating and blocking arteries.
The study is the first to show the clinical consequences of the aspirin/NSAID interaction in patients being treated for prevention of a second stroke, and presents a possible explanation of the mechanism of action.
The Food and Drug Administration currently warns that ibuprofen might make aspirin less effective, but states that the clinical implications of the interaction have not been evaluated.
"This interaction between aspirin and ibuprofen or prescription NSAID's is one of the best-known, but well-kept secrets in stroke medicine," said Francis M. Gengo, Pharm.D., lead researcher on the study.
"It's unfortunate that clinicians and patients often are unaware of this interaction. Whatever number of patients who have had strokes because of the interaction between aspirin and NSAIDs, those strokes were preventable."
Gengo is professor of neurology in the UB School of Medicine and Biomedical Sciences and professor of pharmacy practice in the UB School of Pharmacy and Pharmaceutical Sciences. Results of the study were published in the January issue of the Journal of Clinical Pharmacology.
"We first looked at this issue way back in 1992 in a study conducted in normal volunteers, but it was published as an abstract only," he said. "We never followed through with a manuscript, but another group published an elegant study in the New England Journal of Medicine showing this interaction at least seven years ago.
"When we began to assess this in our stroke patients, a surprisingly high percentage of a group of 653 patients, around 17 percent, were taking aspirin plus Motrin [a brand of ibuprofen].
"The prescription medication Aggrenox, which also is used for secondary stroke prevention and contains aspirin and extended release dipyridamole, is affected the same way as aspirin," Gengo continued. "In preventing strokes, it is statistically a little better than aspirin but more expensive.
"However, one of the most common side effects when you first start taking Aggrenox is headache, so some physicians, pharmacists or physician assistants tell patients to take a Motrin so they don't get a headache. This likely would negate the effects of the aspirin and extended release dipyridamole. Those patients might as well take this expensive drug and flush it down the toilet."
Gengo and colleagues verified with urine testing that all 18 patients, six men and 12 women, were taking their aspirin or aspirin and extended release dipyridamole as directed. Information on the concomitant use of NSAIDS was obtained from patient interviews. Data from the earlier healthy volunteer study showed the magnitude and time course of each drug administered separately, as well as in combination.
The UB study provides important information, Gengo noted, because in most previous studies, measurements were taken only at one point in time, and that time point may have been during the 4-6 hour window when concentrations of NSAIDS were sufficiently high to inhibit aggregation.
"Our data report the entire time course of this interaction," he said. "The results showed that platelets resumed aggregating within 4-6 hours when aspirin and ibuprofen were taken close together, leaving patients with no anti-platelet effect for 18-20 hours a day. Normally, a single dose of aspirin has an effect on platelet aggregation for 72-96 hours," Gengo said.
"When I lecture to pharmacy students, I tell them 'Please, you have a responsibility to the patients you care for. When you counsel a patient taking aspirin/extended release dipyrdamole to lower stroke risk, tell patients they may have some transient headaches, but to avoid ibuprofen. You may have prevented that patient from having another stroke.'"
This study was supported by the Dent Family Foundation.
UB/Dent personnel who also contributed to the study were Michelle Rainka, Pharm.D., UB adjunct instructor of pharmacy practice; Donald E. Mager, Pharm.D., UB assistant professor of pharmaceutical sciences, and Vernice Bates, M.D., UB clinical associate professor of neurology. Matthew Robson and Michael Gengo, research assistants at the Dent Neurologic Institute, and Lisa Rubin, Pharm.D., a former UB student, also contributed to the research.
The University at Buffalo is a premier research-intensive public university, a flagship institution in the State University of New York system and its largest and most comprehensive campus. UB's more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. The School of Medicine and Biomedical Sciences, School of Dental Medicine, School of Nursing, School of Pharmacy and Pharmaceutical Sciences and School of Public Health and Health Professions are the five schools that constitute UB's Academic Health Center. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.
The University at Buffalo
Ibuprofen Current Events and Ibuprofen News RSSCommon Pain Relievers May Dilute Power of Flu Shots
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system.
Oleocanthal may help prevent, treat Alzheimer's
Oleocanthal, a naturally-occurring compound found in extra-virgin olive oil, alters the structure of neurotoxic proteins believed to contribute to the debilitating effects of Alzheimer's disease. This structural change impedes the proteins' ability to damage brain nerve cells.
Ibuprofen is as effective as acetaminophen with codeine to treat pain in children with arm fractures
Children with arm fractures fared as well with ibuprofen to control their pain as acetaminophen with codeine, according to a new study by researchers at the Medical College of Wisconsin, Milwaukee, and Children's Research Institute.
Link between migraines and reduced breast cancer risk confirmed in follow-up study
The relationship between migraine headaches in women and a significant reduction in breast cancer risk has been confirmed in a follow-on study to landmark research published last year and conducted by scientists at Fred Hutchinson Cancer Research Center.
What teens don't know about OTC medications can hurt them
Teens, who are starting to make more decisions about their own health care, may not know enough about over-the-counter pain medications to avoid complications or inadvertent misuse.
When Conservative Treatment Fails: Sonographically-Guided Debridement Offers "Non-Surgical" Method for Chronic Tendinosis of the Achilles Tendon
Researchers have found an alternative, "non-surgical" method to treat chronic tendinosis (tendinitis) of the Achilles tendon that fails conservative treatment, according to a study performed at the Feinberg School of Medicine, Northwestern University in Chicago, IL.
Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease
In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.
Oxycodone effective against shingles pain
The painkiller oxycodone is effective at treating the acute pain of shingles, an illness that often causes severe pain which can become long-lasting and sometimes even permanent.
Licorice compound offers new cancer prevention strategy
A chemical component of licorice may offer a new approach to preventing colorectal cancer without the adverse side effects of other preventive therapies, Vanderbilt University Medical Center researchers report.
First international guidelines for treatment of psoriatic arthritis
Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it.
More Ibuprofen Current Events and Ibuprofen News Articles
 |
Kirkland Signature -IbuprofenTablets USP 200 mg, 1000 Tablet by Kirkland Signature Kirkland Signature Ibuprofen for the temporary relief of minor aches and pains associated with the common cold, headache, toothache, muscular aches, backache, for the minor pain of arthritis, for the pain of menstrual cramps and for the reduction of fever. |
 |
Member's Mark - Ibuprofen Pain Reliever/Fever Reducer 200 mg, 2 Bottles of 500 (Twin Pack) 1000 Tablets by Sam's West, Inc. |
 |
500 Tablets Ibuprofen 200 mg - Compare to Active Ingredient in Advil by Kirkland Kirkland Signature Ibuprofen for the temporary relief of minor aches and pains associated with the common cold, headache, toothache, muscular aches, backache, for the minor pain of arthritis, for the pain of menstrual cramps and for the reduction of fever |
 |
Kirkland Ibuprofen (200 mg), 500-Count Tablets (Pack of 2) by Nutritional Products International Kirkland Signature Ibuprofen for the temporary relief of minor aches and pains associated with the common cold, headache, toothache, muscular aches, and backache, for the minor pain of arthritis, for the pain of menstrual cramps and for the reduction of fever. |
 |
Advil Ibuprofen, 200 mg, Coated Caplets 200 coated caplets by Advil You can't always stop for pain. And pain never stops for you. It's time you advanced to Advil for fast pain relief. Doctors recommend Advil caplets, gel caplets and Advil tablets for headache, muscle aches, backache, and minor arthritis pain. |
 |
Advil Liqui-Gels-Ibuprofen Pain Reliever, 240ct by Advil Advanced Medicine For PainÂŽ |
 |
Kirkland Signature Ibuprofen Tablets USP 200 mg Pain Reliever, Fever Reducer - Compare to Advil - 500 Tablets by Kirkland Signature |
 |
Equate - Ibuprofen Pain Reliever/Fever Reducer 200 mg, 500 Coated Tablets (Compare to Advil) by Perrigo. |
 |
Equate - Ibuprofen Pain Reliever/fever Reducer 200 Mg, 500 Tablets (Compare to Advil) by Perrigo. |
 |
First Aid Only Ibuprofen Tablets, 50 2-packs, 100-Count Boxes (Pack of 3) by First Aid Only Comparable to Advilâ and Motrinâ, these ibuprofen tablets offer temporary relief of minor aches and pains associated with the common cold, headache, toothache, muscle aches, backache, menstrual cramps and arthritis. Also useful for reducing fever. Active ingredient: ibuprofen, 200 mg. |
| © 2009 BrightSurf.com |